Form 483

UMEDICA LABORATORIES PRIVATE LIMITED Form 483, 2017-05-19

FDA issued a Form 483 to UMEDICA LABORATORIES PRIVATE LIMITED on 2017-05-19 with 9 public-safe observations.

483· Form 483 issuedHuman Drugs9 observations

UMEDICA LABORATORIES PRIVATE LIMITED · Vapi, India · Issued May 19, 2017

Overview

  • 9 public-safe observations are available for this inspection.
  • 3 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

19 May 2017
21 CFR 211.100(b)

SOPs not followed / documented

Cited by Alan P Kurtzberg

19 May 2017
21 CFR 211.100(b)

SOPs not followed / documented

Cited by Alan P Kurtzberg

19 May 2017
21 CFR 211.188

Prepared for each batch, include complete information

Cited by Alan P Kurtzberg

19 May 2017
21 CFR 211.188

Prepared for each batch, include complete information

Cited by Alan P Kurtzberg

19 May 2017
21 CFR 211.188(b)(12)

Investigations made into any unexplained discrepancy

Cited by Alan P Kurtzberg

Inspected site

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.100(b)Cited across public-safe Form 483 observations3x
21 CFR 211.188Cited across public-safe Form 483 observations3x
21 CFR 211.188(b)(12)Cited across public-safe Form 483 observations3x

Full 483 report

Get the verbatim text of all 9 observations

The full inspection record, as Atlas holds it, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere